Medicare Enrolled

Dr. Serge Menkin, M.D.

Sports Medicine (Orthopaedic Surgery) Physician · Jersey City, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
311 NEWARK AVE, Jersey City, NJ 07302
2015330055
In practice since 2005 (20 years)
NPI: 1881670784 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Menkin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menkin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Menkin

Dr. Serge Menkin is a sports medicine physician in Jersey City, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Menkin performed 1,434 Medicare services across 614 unique beneficiaries.

Between the years covered by Open Payments, Dr. Menkin received a total of $4,185 from 34 pharmaceutical and/or device companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine (orthopaedic surgery) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Menkin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,434 Medicare services $4,185 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,434
Medicare services
Bottom 45% in NJ for sports medicine (orthopaedic surgery) physician
614
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~72 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
552 $68 $281
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
283 $105 $426
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
110 $9 $25
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
85 $0 $32
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
72 $89 $1,444
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
68 $49 $879
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $138 $527
Viscosupplementation injection for joint
An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning.
44 $56 $247
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
39 $110 $6,969
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
30 $91 $4,543
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
25 $51 $1,036
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
17 $9 $395
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
16 $110 $5,977
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
15 $42 $4,295
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
15 $61 $3,900
Spinal nerve root injection with imaging guidance
An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement.
12 $104 $3,969
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,185
Total received (2018-2024)
Avg $598/year across 7 years
Top 47% in NJ for sports medicine (orthopaedic surgery) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
261
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,185 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$347
2023
$321
2022
$461
2021
$593
2020
$464
2019
$925
2018
$1,073

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Vertos Medical, Inc.
$140
SPR Therapeutics, Inc
$113
Collegium Pharmaceutical, Inc.
$61
Abbott Laboratories
$18
SCILEX PHARMACEUTICALS INC.
$15
Top 3 companies account for 90.3% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$1,087
Horizon Therapeutics plc
$479
NuVasive, Inc.
$435
Daiichi Sankyo Inc.
$421
Nalu Medical, Inc.
$153
Vertos Medical, Inc.
$140
Sentynl Therapeutics, Inc.
$134
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$132
PFIZER INC.
$119
Biohaven Pharmaceuticals, Inc.
$115
SPR Therapeutics, Inc
$113
Pernix Therapeutics Holdings, Inc.
$89
Boston Scientific Corporation
$85
IDORSIA PHARMACEUTICALS US INC
$67
Horizon Pharma plc
$65
Almatica Pharma LLC
$64
Indivior Inc.
$62
Scilex Pharmaceuticals Inc.
$57
BioDelivery Sciences International, Inc.
$54
SCILEX PHARMACEUTICALS INC.
$40
DePuy Synthes Sales Inc.
$38
Shionogi Inc
$32
Assertio Therapeutics, Inc.
$31
Virtus Pharmaceuticals LLC
$24
Abbott Laboratories
$18
Zimmer Biomet Holdings, Inc.
$18
Kaleo, Inc.
$17
Pacira Pharmaceuticals Incorporated
$15
FIDIA PHARMA USA INC.
$15
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$15
Egalet US Inc
$14
SPINEFRONTIER, INC.
$13
Amneal Pharmaceuticals LLC
$12
Bioventus LLC
$11
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
BELBUCA · BUNAVAIL 2.1 mg 30-count box · DUEXIS · Durolane · ETERNA · EVZIO · Exparel · FLECTOR · GRALISE · Gel-One Cross-linked Hyaluronate · Gralise · Hymovis · Inspan · LEVORPHANOL TARTRATE · LYRICA · Levorphanol · Levorphanol Tartrate · MONOVISC · Morphabond ER · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Nucynta · ORTHOVISC · PENNSAID · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REYVOW · RYTARY · SPRINT PNS System · SPRIX · SUBLOCADE · SUPERION · Spectra WaveWriter · Symproic · TREXIMET · VIMOVO · VuePoint · XLIF · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a sports medicine physician in Jersey City?
Compare sports medicine physicians in the Jersey City area by procedure volume, costs, and industry payment transparency.
Browse sports medicine physicians nearby

Geographic Context

Sports medicine physicians within 10 mi
161
Per 100K population
22.7
County median income
$90,032
Nearest hospital
JERSEY CITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Menkin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Menkin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Menkin performed 552 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Menkin receive payments from pharmaceutical companies?
Yes. Dr. Menkin received a total of $4,185 from 34 companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menkin's costs compare to other sports medicine physicians in Jersey City?
Dr. Menkin's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menkin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →